UV Water Treatment for Gastroenteritis in Children
(WET Trial)
Trial Summary
What is the purpose of this trial?
Approximately 40 million people in the US are served by private, and frequently untreated, wells. Our best estimate is that 1.3 million cases of gastrointestinal illnesses (GI) per year are attributed to consuming water from untreated private wells in the US, but in reality, there are no robust epidemiological data that can be used to estimate cases of GI attributable to these sources. We propose the first randomized controlled trial (RCT) to estimate the burden of GI associated with private well water. We will test if household treatment of private well water by ultraviolet light (UV) vs. sham (inactive UV device) decreases the incidence of GI in children under 5. We will also examine the presence of viral, bacterial, and protozoan pathogens in stool and well water from participants. These data will fill a knowledge gap on sporadic GI associated with federally-unregulated private water supplies in the US.
Will I have to stop taking my current medications?
The trial does not specify if participants need to stop taking their current medications. However, children taking daily oral steroids are excluded from participating.
What data supports the effectiveness of the UV water treatment for gastroenteritis in children?
Is UV water treatment safe for humans?
How does the UV Water Treatment for Gastroenteritis in Children differ from other treatments?
Research Team
Heather M Murphy, PhD
Principal Investigator
Temple University
Eligibility Criteria
This trial is for children under 5 years old who drink untreated well water and live in specific counties of Pennsylvania. They must be full-time residents at a home served by a private well, and their parent or guardian needs to have texting capabilities on their phone. Children who only drink bottled water, are immunocompromised, have chronic GI conditions, or take daily oral steroids cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either an active UV device or a sham UV device for water treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Active UV Device
- Inactive UV Device
Active UV Device is already approved in United States, European Union, Canada for the following indications:
- Disinfection of private well water to reduce gastrointestinal illnesses
- Water treatment for drinking water systems
- Reduction of microbiological contaminants in water
- Disinfection of drinking water
- Reduction of bacteria, viruses, and protozoa in water
Find a Clinic Near You
Who Is Running the Clinical Trial?
Temple University
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator